RET fusion as a treatable resistance mechanism in EGFR mutation lung cancer - A case report

被引：0
|
作者：
Athipatla, Vivek [1 ]
Hall, Ashley [2 ]
Dahiya, Marta [2 ]
Narra, Kalyani [2 ]
机构：
[1] Carroll Med Acad, Southlake, TX USA
[2] JPS Oncol & Infus Ctr, Ft Worth, TX USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.93
引用
收藏
页码：E41 / E41
页数：1
相关论文
共 50 条
  • [21] RET rearrangement as a mechanism of resistance to ALK-TKI in non-small cell lung cancer patient with EML4-ALK fusion: A case report
    Yan, Huan
    Zeng, Liang
    Zhang, Yongchang
    HELIYON, 2024, 10 (09)
  • [22] Concomitant Presence of EGFR and ALK Fusion Gene Mutation in Adenocarcinoma of Lung: A Case Report and Review of the Literature
    Thumallapally, Nishitha
    Yu, Hana
    Farhan, Mohammad
    Ibrahim, Uroosa
    Odiami, Maricel
    JOURNAL OF PHARMACY PRACTICE, 2018, 31 (02) : 244 - 248
  • [23] Adenocarcinoma of the lung with concomitant ALK fusion gene and EGFR gene mutation: A case report and literature review
    Fan, Tao
    Song, Ying-Jie
    Liu, Xiu-Li
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (02) : 203 - 205
  • [24] Bevacizumab to combat EGFR-TKI resistance in a patient with advanced non-small cell lung cancer harboring an EGFR mutation: A case report
    Wang, Zhiyi
    Zhou, Pu
    Li, Guanghui
    ONCOLOGY LETTERS, 2016, 12 (01) : 356 - 360
  • [25] ErlotinibAcquired drug resistance following EGFR mutation: case report
    Reactions Weekly, 2017, 1658 (1) : 184 - 184
  • [26] RET fusion in advanced non-small-cell lung cancer and response to cabozantinib A case report
    Wang, Yucong
    Xu, Yinghui
    Wang, Xu
    Sun, Chao
    Guo, Ye
    Shao, Guoguang
    Yang, Zhiguang
    Qiu, Shi
    Ma, Kewei
    MEDICINE, 2019, 98 (03)
  • [27] MET-UBE2H fusion as a novel mechanism of acquired EGFR resistance in lung adenocarcinoma" with "MET fusion as a novel mechanism of acquired EGFR resistance in lung adenocarcinoma
    Wang, W.
    Xu, C.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Song, Z.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1032 - S1032
  • [28] Management of tyrosine kinase inhibitor resistance in lung cancer with EGFR mutation
    Becker, Kevin
    Xu, Yiqing
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 560 - 567
  • [29] Acquired KRAS mutation as mechanism of resistance to EGFR inhibition in colorectal cancer
    Liska, David
    Janakiraman, Manickam
    Chen, Chin-Tung
    Ding, Pei-Rong
    Solit, David B.
    Weiser, Martin R.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (03) : S126 - S126
  • [30] CrizotinibDevelopment of resistance mutation in lung adenocarcinoma: case report
    Reactions Weekly, 2017, 1641 (1) : 92 - 92
12345